Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subcutaneous Injection”

891 trials

Showing 20 of 891 results

Early research (Phase 1)Study completedNCT05978713
What this trial is testing

Tirzepatide (LY3298176) in Healthy Lactating Females

Who this might be right for
Healthy
Eli Lilly and Company 11
Early research (Phase 1)Study completedNCT03586843
What this trial is testing

JNJ-64565111 After Single Subcutaneous Administration at Different Injection Sites in Otherwise Healthy Overweight/Obese Adult Participants and a Study of JNJ-6456511 in Otherwise Healthy Obese Adult Participants After Multiple Dose

Who this might be right for
Obesity
Janssen Research & Development, LLC 52
Testing effectiveness (Phase 2)Study completedNCT02313155
What this trial is testing

Phase 1/2 Study of TAK-850 Subcutaneous Injection in Healthy Adults

Who this might be right for
Influenza Infection
Takeda 110
Early research (Phase 1)Study completedNCT01638325
What this trial is testing

Insulin Lispro With BioChaperone Excipient in Healthy Participants

Who this might be right for
Healthy Participants
Adocia 37
Early research (Phase 1)Study completedNCT07466940
What this trial is testing

A Clinical Study to Evaluate SM17 in Healthy Participants

Who this might be right for
Atopic DermatitisAsthmaInflammatory Bowel Disease
SinoMab BioScience Ltd 30
Large-scale testing (Phase 3)Study completedNCT01746862
What this trial is testing

Evaluate the Safety and Efficacy of Saizen® in Children With Idiopathic Short Stature (ISS)

Who this might be right for
Idiopathic Short Stature
Merck KGaA, Darmstadt, Germany 90
Early research (Phase 1)Study completedNCT04653168
What this trial is testing

LY3041658 in Healthy Participants

Who this might be right for
Healthy
Eli Lilly and Company 16
Testing effectiveness (Phase 2)Study completedNCT00730210
What this trial is testing

Treatment of Hypoparathyroidism With Subcutaneous PTH (1-84) Injections: Effects on Muscle Function and Quality of Life

Who this might be right for
Hypoparathyroidism
University of Aarhus 62
Early research (Phase 1)Study completedNCT07200596
What this trial is testing

The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of SHR-3045 in Healthy Subjects

Who this might be right for
Rheumatoid Arthritis (RA)
Guangdong Hengrui Pharmaceutical Co., Ltd 16
Early research (Phase 1)Study completedNCT04699669
What this trial is testing

Evaluate the Safety and Tolerability of CBL-514 Injection on Convexity or Fullness of Abdominal Subcutaneous Fat in Healthy Volunteers

Who this might be right for
Subcutaneous Fat
Caliway Biopharmaceuticals Co., Ltd. 40
Not applicableLooking for participantsNCT06427876
What this trial is testing

Fasenra Pediatric Japan Post-Marketing Study(PMS)

Who this might be right for
Bronchial Asthma
AstraZeneca 40
Early research (Phase 1)Study completedNCT01443650
What this trial is testing

Injection Site Tolerability, Safety, Pharmacokinetics, Pharmacodynamics in Different Single-Dose Treatments of Alirocumab SAR236553 (REGN727) in Healthy Subjects

Who this might be right for
Hypercholesterolemia
Sanofi 36
Testing effectiveness (Phase 2)Looking for participantsNCT06524635
What this trial is testing

Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab

Who this might be right for
Hidradenitis SuppurativaAtopic Dermatitis
AbbVie 60
Testing effectiveness (Phase 2)Study completedNCT05234736
What this trial is testing

Evaluate the Pharmacokinetic Profile of CBL-514 Injection in Healthy Volunteers

Who this might be right for
Subcutaneous Fat
Caliway Biopharmaceuticals Co., Ltd. 10
Early research (Phase 1)Study completedNCT04903509
What this trial is testing

A Study in Men With Overweight to Test How Well Different Doses of BI 1820237 Are Tolerated When Given as an Injection Alone or in Combination With Liraglutide

Who this might be right for
Healthy
Boehringer Ingelheim 95
Early research (Phase 1)Study completedNCT06167707
What this trial is testing

Pharmacokinetics and Pharmacodynamics of Subcutaneous vs Intravenous Furosemide in Healthy Volunteers

Who this might be right for
Heart FailureFluid Overload
scPharmaceuticals, Inc. 21
Early research (Phase 1)Study completedNCT04434300
What this trial is testing

Subcutaneous Daptomycin in Healthy Volunteers (DAPTOSC)

Who this might be right for
AntibioticsSubcutaneous InjectionDaptomycin
University Hospital, Caen 12
Early research (Phase 1)Looking for participantsNCT05318534
What this trial is testing

Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Male and Female Subjects and Safety, Tolerability, Pharmacokinetics, and Pilot Efficacy Biomarkers in Subjects With Cold Agglutinin Disease

Who this might be right for
First in Man Study to Evaluate Initial Safety
Gliknik Inc. 70
Early research (Phase 1)Not Yet RecruitingNCT07535775
What this trial is testing

Evaluate Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of BCD-261 After Single Subcutaneous Injection in Healthy Chinese Volunteers

Who this might be right for
Healthy Adult Participants
SPH-BIOCAD (HK) Limited 48
Early research (Phase 1)Study completedNCT00614029
What this trial is testing

Evaluate the Pharmacokinetics and Bioequivalence of Sumatriptan Delivered Via the Intraject System

Who this might be right for
PharmacokineticsBioequivalence
Zogenix, Inc. 54
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation